Literature DB >> 27605538

The clinical and phenotypical assessment of seronegative villous atrophy; a prospective UK centre experience evaluating 200 adult cases over a 15-year period (2000-2015).

Imran Aziz1,2, Mohammad F Peerally1, Jodie-Hannah Barnes1,2, Vigneswaran Kandasamy1,2, Jack C Whiteley1,2, David Partridge3, Patricia Vergani4, Simon S Cross2,4, Peter H Green5, David S Sanders1,2.   

Abstract

BACKGROUND: Seronegative villous atrophy (SNVA) is commonly attributed to coeliac disease (CD). However, there are other causes of SNVA. More recently angiotensin-2-receptor-blockers (A2RBs) have been reported as an association but data on SNVA have been limited to centres evaluating complex case referrals and not SNVA in general.
OBJECTIVES: To provide clinical outcomes and associations in a large prospective study overseeing all newcomers with SNVA.
DESIGN: Over a 15-year period (2000-2015) we evaluated 200 adult patients with SNVA at a UK centre. A diagnosis of either seronegative CD (SNCD) or seronegative non-CD (SN-non-CD) was reached. Baseline comparisons were made between the groups, with 343 seropositive CD subjects serving as controls.
RESULTS: Of the 200 SNVA cases, SNCD represented 31% (n=62) and SN-non-CD 69% (n=138). The human leucocyte antigen (HLA)-DQ2 and/or DQ8 genotype was present in 61%, with a 51% positive predictive value for SNCD. The breakdown of identifiable causes in the SN-non-CD group comprised infections (27%, n=54), inflammatory/immune-mediated disorders (17.5%, n=35) and drugs (6.5%, n=13; two cases related to A2RBs). However, no cause was found in 18% (n=36) and of these 72% (n=26/36) spontaneously normalised duodenal histology while consuming a gluten-enriched diet. Following multivariable logistic regression analysis an independent factor associated with SN-non-CD was non-white ethnicity (OR 10.8, 95% CI 2.2 to 52.8); in fact, 66% of non-whites had GI infections. On immunohistochemistry all groups stained positive for CD8-T-cytotoxic intraepithelial lymphocytes. However, additional CD4-T helper intraepithelial lymphocytes were occasionally seen in SN-non-CD mimicking the changes associated with refractory CD.
CONCLUSIONS: Most patients with SNVA do not have CD, in particular those who are not white. Furthermore, a subgroup with no obvious aetiology will show spontaneous histological resolution while consuming gluten. These findings suggest caution in empirically prescribing a gluten-free diet without investigation. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  CELIAC DISEASE; SMALL BOWEL DISEASE; SMALL INTESTINAL BIOPSY

Mesh:

Substances:

Year:  2016        PMID: 27605538     DOI: 10.1136/gutjnl-2016-312271

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  29 in total

Review 1.  A Comprehensive Review of Celiac Disease/Gluten-Sensitive Enteropathies.

Authors:  Brian P McAllister; Emmanuelle Williams; Kofi Clarke
Journal:  Clin Rev Allergy Immunol       Date:  2019-10       Impact factor: 8.667

2.  The CD That Pays Dividends: More Than 15 Years of Deamidated Gliadin Peptide Antibodies.

Authors:  Julio C Bai; Elena F Verdú
Journal:  Dig Dis Sci       Date:  2017-05       Impact factor: 3.199

Review 3.  How to manage adult coeliac disease: perspective from the NHS England Rare Diseases Collaborative Network for Non-Responsive and Refractory Coeliac Disease.

Authors:  Elisabeth Megan Rose Baggus; Marios Hadjivassiliou; Simon Cross; Hugo Penny; Heidi Urwin; Sarah Watson; Jeremy Mark Woodward; David S Sanders
Journal:  Frontline Gastroenterol       Date:  2019-08-08

4.  Seronegative enteropathy and malnutrition: a diagnostic challenge.

Authors:  James McCulloch; Miriam Barclay; Adam Levene; Robert Fearn
Journal:  BMJ Case Rep       Date:  2018-05-26

Review 5.  Celiac Disease Revisited.

Authors:  João Calado; Mariana Verdelho Machado
Journal:  GE Port J Gastroenterol       Date:  2021-03-17

6.  Clinical classification and long-term outcomes of seronegative coeliac disease: a 20-year multicentre follow-up study.

Authors:  Annalisa Schiepatti; Anupam Rej; Stiliano Maimaris; Simon S Cross; Petra Porta; Imran Aziz; Tim Key; John Goodwin; Amelie Therrien; Shakira Yoosuf; Daniel A Leffler; Jocelyn A Silvester; Catherine Klersy; Federico Biagi; David S Sanders
Journal:  Aliment Pharmacol Ther       Date:  2021-09-08       Impact factor: 8.171

7.  Evolving patterns in the presentation of coeliac disease over the last 25 years.

Authors:  Callan Stroud; Orouba Almilaji; David Nicholas; Silvia Kirkham; Susan L Surgenor; Imogen Williams; Jonathon Snook
Journal:  Frontline Gastroenterol       Date:  2019-06-04

8.  Improving basic skills in celiac-like disease diagnosis: a case report.

Authors:  Vito Domenico Corleto; Vincenza Patrizia Di Marino; Gloria Galli; Giulio Antonelli; Chiara Coluccio; Arcangelo Di Cerbo; Stefania Uccini; Bruno Annibale
Journal:  BMC Gastroenterol       Date:  2018-11-03       Impact factor: 3.067

Review 9.  Pitfalls in the Diagnosis of Coeliac Disease and Gluten-Related Disorders.

Authors:  Annalisa Schiepatti; Jessica Savioli; Marta Vernero; Federica Borrelli de Andreis; Luca Perfetti; Antonio Meriggi; Federico Biagi
Journal:  Nutrients       Date:  2020-06-07       Impact factor: 5.717

Review 10.  The serological diagnosis of coeliac disease - a step forward.

Authors:  Geoffrey Holmes; Carolina Ciacci
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2018
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.